MX2024001360A - Antigeno recombinante para la induccion de respuesta inmune contra el virus zika. - Google Patents
Antigeno recombinante para la induccion de respuesta inmune contra el virus zika.Info
- Publication number
- MX2024001360A MX2024001360A MX2024001360A MX2024001360A MX2024001360A MX 2024001360 A MX2024001360 A MX 2024001360A MX 2024001360 A MX2024001360 A MX 2024001360A MX 2024001360 A MX2024001360 A MX 2024001360A MX 2024001360 A MX2024001360 A MX 2024001360A
- Authority
- MX
- Mexico
- Prior art keywords
- zika virus
- inducing
- immune response
- response against
- chimeric antigen
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 5
- 102000036639 antigens Human genes 0.000 title abstract 5
- 108091007433 antigens Proteins 0.000 title abstract 5
- 241000907316 Zika virus Species 0.000 title abstract 3
- 230000028993 immune response Effects 0.000 title abstract 3
- 230000001939 inductive effect Effects 0.000 title abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 5
- 101500010370 Zika virus Capsid protein C Proteins 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 108090000565 Capsid Proteins Proteins 0.000 abstract 1
- 102100023321 Ceruloplasmin Human genes 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 239000012646 vaccine adjuvant Substances 0.000 abstract 1
- 229940124931 vaccine adjuvant Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Una afeitadora incluye una carcasa (12) que incluye primera y segunda mitades de la carcasa (12a, 12b) definiendo una cámara interior (32), la carcasa teniendo un extremo operativo (14) y un extremo 5 inferior opuesto (16), la cámara interior conteniendo un motor (34) que actúa a través de una transmisión (36) y configurado para conducir recíprocamente un par de dedos impulsores alternativos laterales (38, 40). Cada dedo impulsor incluye un elemento de accionamiento de dedo alargado (42) extendiéndose desde el extremo operativo. Un sello resistente (50) que tiene ranuras (52) que acomodan los elementos de los dedos impulsores se captura en cavidades de sello correspondientes 10 (54) en cada una de las mitades de la carcasa. El sello y las mitades de la carcasa están configurados para colocar el sello en al menos una de la compresión radial y axial en el montaje de las mitades de la carcasa juntas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU2021000063A CU20210063A7 (es) | 2021-07-28 | 2021-07-28 | Antígeno recombinante para la inducción de respuesta inmune contra el virus zika |
| PCT/CU2022/050008 WO2023006131A1 (es) | 2021-07-28 | 2022-07-21 | Antigeno recombinante para la induccion de respuesta inmune contra el virus zika |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024001360A true MX2024001360A (es) | 2024-02-14 |
Family
ID=83005857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024001360A MX2024001360A (es) | 2021-07-28 | 2022-07-21 | Antigeno recombinante para la induccion de respuesta inmune contra el virus zika. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4378475A1 (es) |
| JP (1) | JP2024527039A (es) |
| KR (1) | KR20240038009A (es) |
| CN (1) | CN117979993A (es) |
| AU (1) | AU2022320680A1 (es) |
| CA (1) | CA3227009A1 (es) |
| CU (1) | CU20210063A7 (es) |
| MX (1) | MX2024001360A (es) |
| WO (1) | WO2023006131A1 (es) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112018016755A2 (pt) * | 2016-02-17 | 2018-12-26 | Curevac Ag | vacina contra o vírus da zica |
-
2021
- 2021-07-28 CU CU2021000063A patent/CU20210063A7/es unknown
-
2022
- 2022-07-21 CA CA3227009A patent/CA3227009A1/en active Pending
- 2022-07-21 WO PCT/CU2022/050008 patent/WO2023006131A1/es active Application Filing
- 2022-07-21 CN CN202280058340.2A patent/CN117979993A/zh active Pending
- 2022-07-21 JP JP2024504927A patent/JP2024527039A/ja active Pending
- 2022-07-21 AU AU2022320680A patent/AU2022320680A1/en active Pending
- 2022-07-21 MX MX2024001360A patent/MX2024001360A/es unknown
- 2022-07-21 KR KR1020247005128A patent/KR20240038009A/ko unknown
- 2022-07-21 EP EP22757824.2A patent/EP4378475A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3227009A1 (en) | 2023-02-02 |
| KR20240038009A (ko) | 2024-03-22 |
| EP4378475A1 (en) | 2024-06-05 |
| CN117979993A (zh) | 2024-05-03 |
| WO2023006131A1 (es) | 2023-02-02 |
| JP2024527039A (ja) | 2024-07-19 |
| CU20210063A7 (es) | 2023-03-07 |
| AU2022320680A1 (en) | 2024-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6874031B2 (ja) | アイメリアに対する免疫応答を強化するか又はアイメリア感染症を制限する組成物及び方法 | |
| RU2016146801A (ru) | Вакцинная композиция против инфекции, вызванной streptococcus suis | |
| WO2021249116A9 (en) | Coronavirus vaccine compositions, methods, and uses thereof | |
| FI2970398T3 (fi) | Rsv f -prefuusioproteiineja ja niiden käyttö | |
| JP2020528911A5 (es) | ||
| JP7146926B2 (ja) | Ｃｄ４ヘルパーｔ細胞エピトープの融合ペプチドおよびそのワクチン | |
| MX2021014497A (es) | Peptidos. | |
| DK2491946T3 (en) | Adjuvant for vaccines | |
| US20190358313A1 (en) | New flavivirus vaccine | |
| MX2024001360A (es) | Antigeno recombinante para la induccion de respuesta inmune contra el virus zika. | |
| PH12020500194A1 (en) | Malaria vaccine | |
| WO2021249013A9 (en) | Vaccine compositions, methods, and uses thereof | |
| JP2020515283A5 (es) | ||
| JP6373601B2 (ja) | アカバネウイルスに対して中和活性を有する抗体を誘導するペプチド | |
| BR112022017967A2 (pt) | Peptídeo cíclico; composição farmacêutica; método para tratar uma doença neurodegenerativa; método para induzir uma resposta imune em um indivíduo; polipeptídeo cíclico; método para produzir um peptídeo cíclico; e método para a geração de um anticorpo | |
| KR101366702B1 (ko) | 호흡기 신시치아 바이러스 백신 조성물 및 그의 제조방법 | |
| RU2024104848A (ru) | Рекомбинантный антиген для индукции иммунного ответа против вируса зика | |
| JP2017509597A5 (es) | ||
| EP0542895B1 (en) | Cross-reactive influenza a immunization | |
| CN115850398B (zh) | 新型冠状病毒奥密克戎系列变异株的多肽组合物及其应用 | |
| CN109182430B (zh) | 一种流感疫苗免疫佐剂 | |
| CA3076263C (en) | Synthetic hemagglutinin as universal vaccine against infection by type b influenza viruses (ibv) | |
| CN109097425B (zh) | 一种多肽及用作流感疫苗免疫佐剂的用途 | |
| CN109082453B (zh) | 一种多肽作为流感疫苗佐剂提高流感疫苗免疫效果的用途 | |
| RU2019113940A (ru) | Мозаичные вакцины от вируса ящура серотипа а |